ERBB2 and neoplasm: To evaluate the potential treatment-independent effects of HER2 overexpression, immune cell infiltration in TAXHER01 tumours was compared with that in HER2-positive tumour subgroups of the control groups (HER2 control, n=15) (Table 3).